CoChat

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice

Open access
Alves, Sandro, Churlaud, Guillaume, Audrain, Mickael, Michaelsen-Preusse, Kristin, Fol, Romain, Souchet, Benoit, Braudeau, Jérôme, Korte, Martin, Klatzmann, David, Cartier, Nathalie · 2016 · Brain
Cited by 172

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Interleukin-2 (IL-2)-deficient mice have cytoarchitectural hippocampal modifications and impaired learning and memory ability reminiscent of Alzheimer's disease. IL-2 stimulates regulatory T cells whose role is to control inflammation. As neuroinflammation contributes to neurodegeneration, we investigated IL-2 in Alzheimer's disease. Therefore, we investigated IL-2 levels in hippocampal biopsies of patients with Alzheimer's disease relative to age-matched control individuals. We then treated APP/PS1ΔE9 mice having established Alzheimer's disease with IL-2 for 5 months using single administration of an AAV-IL-2 vector. We first found decreased IL-2 levels in hippocampal biopsies of patients with Alzheimer's disease. In mice, IL-2-induced systemic and brain regulatory T cells expansion and activation. In the hippocampus, IL-2 induced astrocytic activation and recruitment of astrocytes around amyloid plaques, decreased amyloid-β42/40 ratio and amyloid plaque load, improved synaptic plasticity and significantly rescued spine density. Of note, this tissue remodelling was associated with recovery of memory deficits, as assessed in the Morris water maze task. Altogether, our data strongly suggest that IL-2 can alleviate Alzheimer's disease hallmarks in APP/PS1ΔE9 mice with established pathology. Therefore, this should prompt the investigation of low-dose IL-2 in Alzheimer's disease and other neuroinflammatory/neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/aww330

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. 10.1002/jnr.490350310 · DOI · Paper page
  2. 10.2337/db13-0214 · DOI
  3. 10.1016/j.bbi.2003.09.013 · DOI
  4. Barcia, 2013, Imaging the microanatomy of astrocyte-T-cell interactions in immune-mediated inflammation, Front Cell Neurosci, 7, 58, 10.3389/fncel.2013.00058 · DOI
  5. 10.1073/pnas.1015239108 · DOI · Paper page
  6. Beck, 2005, IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins, J Neuroimmunol, 160, 146, 10.1016/j.jneuroim.2004.11.006 · DOI
  7. Beloosesky, 2002, Cytokine levels and phagocytic activity in patients with Alzheimer's disease, Gerontology, 48, 128, 10.1159/000052830 · DOI
  8. 10.1186/1742-2094-11-25 · DOI · Paper page
  9. 10.1001/jamadermatol.2014.504 · DOI · Paper page
  10. 10.1038/mp.2008.105 · DOI · Paper page
  11. 10.1016/j.clim.2014.02.003 · DOI
  12. 10.1016/j.jri.2007.06.051 · DOI
  13. 10.1093/brain/awv408 · DOI · Paper page
  14. Eizenberg, 1995, Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes, J Neurochem, 64, 1928, 10.1046/j.1471-4159.1995.64051928.x · DOI · Paper page
  15. 10.1016/S0306-4522(97)00040-7 · DOI
  16. 10.1016/S2213-8587(13)70113-X · DOI · Paper page
  17. He, 2016, Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus, Nat Med, 22, 991, 10.1038/nm.4148 · DOI · Paper page
  18. 10.3109/10799899909036638 · DOI · Paper page
  19. 10.1038/ni.3102 · DOI · Paper page
  20. 10.1002/emmm.201201544 · DOI · Paper page
  21. 10.1038/gt.2011.126 · DOI · Paper page
  22. 10.1038/nri3823 · DOI · Paper page
  23. 10.1037/0735-7044.113.5.1030 · doi:10.1037/0735-7044.113.5.1030
  24. 10.1038/embor.2013.117 · DOI
  25. 10.1186/s12974-015-0243-6 · DOI · Paper page
  26. 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
  27. 10.1016/j.neurobiolaging.2012.02.015 · DOI · Paper page
  28. 10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.0.CO;2-G · doi:10.1002/(sici)1097-4547(19990515)56:4<441::aid-jnr11>3.0.co;2-g
  29. Petitto, 2015, Effects of brain-derived IL–2 deficiency and the development of autoimmunity on spatial learning and fear conditioning, J Neurol Disord, 3, 196, 10.4172/2329-6895.1000196 · DOI
  30. 10.1002/glia.20599 · DOI · Paper page
  31. 10.1016/j.jaut.2015.01.001 · DOI · Paper page
  32. 10.1056/NEJMoa1105143 · DOI · Paper page
  33. 10.1016/j.cell.2008.05.009 · DOI · Paper page
  34. Sarder, 1993, Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain, Brain Res, 625, 347, 10.1016/0006-8993(93)91080-C · DOI
  35. 10.1016/0006-8993(95)01291-5 · doi:10.1016/0006-8993(95)01291-5
  36. Schwab, 2008, Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders, J Alzheimers Dis, 13, 359, 10.3233/JAD-2008-13402 · DOI · Paper page
  37. Shao, 1997, Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study, J Neuropathol Exp Neurol, 56, 376, 10.1097/00005072-199704000-00006 · DOI · Paper page
  38. 10.1002/ar.21118 · DOI
  39. 10.1016/j.neuron.2006.01.022 · DOI · Paper page
  40. 10.1196/annals.1403.002 · DOI · Paper page
  41. 10.1038/jcbfm.2014.125 · DOI · Paper page
  42. 10.1016/0361-9230(94)90005-1 · DOI
  43. 10.1038/nbt1073 · DOI · Paper page
  44. 10.1038/ni.1818 · DOI · Paper page
  45. 10.1046/j.1471-4159.2003.02018.x · DOI · Paper page

Cited by

See all 172

Metadata

Authors
Alves, S., Churlaud, G., Audrain, M., Michaelsen-Preusse, K., Fol, R., Souchet, B., Braudeau, J., Korte, M., Klatzmann, D., & Cartier, N.
Venue
Brain
Published
2016-12-20
Volume
140
Issue
3
Pages
aww330
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2561221875
Cited by
172
References
28
FWCI
7.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.